Prostate cancer decisions — 2015

The Veteran's claims for prostate cancer, diabetes mellitus, lung condition, colon cancer, and skin condition are being remanded due to the need for additional development.

The Veteran's claim for service connection for prostate cancer is being remanded due to the need for a VA examination and further development of his asbestos exposure history. The Board will consider whether there is any link between his in-service genitourinary system problems or other aspects of his active duty service and his current prostate cancer.

The Veteran's claim for service connection for prostate cancer, based on herbicide exposure in Vietnam, was denied as there is no evidence of his having served in the Republic of Vietnam.

The Veteran's prostate cancer status post radioactive seed placement was reduced from 100% to 40%, effective November 1, 2011. The reduction was improper and the rating should be restored.

The Veteran died in February 2004 from cardiac arrest due to myocardial infarction. The appellant claims that the cause of death was prostate cancer, which she believes was caused by radiation exposure during service. The Board is requesting an amended death certificate and a statement from Dr. Rothman regarding any amendments made.

The Veteran's service-connected prostate cancer, status post radical retropubic prostatectomy, renders him unable to maintain gainful employment.

The Veteran's prostate cancer residuals have been rated at 40 percent from November 1, 2007 to August 31, 2009 and at 60 percent as of June 1, 2013. The rating for erectile dysfunction remains at zero percent.

The Veteran seeks service connection for prostate cancer, bladder cancer, colon polyps, and a heart disorder. The Board finds that additional development is necessary due to the lack of evidence regarding his exposure to Agent Orange during his tour of duty aboard the U.S.S. Lynde McCormick.

The Veteran's death was not caused by his service-connected conditions, and the criteria for DIC under 38 U.S.C.A. § 1318 are not met.

The Board found no evidence of herbicide exposure during service and denied the Veteran's claims for diabetes mellitus and prostate cancer as they are not related to his military service.

The Board denied the Veteran's claims for service connection for prostate cancer, erectile dysfunction, urinary incontinence, and neuropathy of the upper and lower extremities. The evidence did not support a finding that these conditions were related to service or any specific exposure.

The February 2009 reduction of the 100 percent rating to 40 percent was proper.

The Veteran's emergency room care at Florida Hospital Medical Center on November 24, 2010 was found to meet the criteria for reimbursement due to his service-connected disabilities resulting in total disability.

The Board has granted the Veteran's claim for service connection for prostate cancer, finding that his condition is related to his military service.

The Veteran's appeal is remanded due to insufficient clarification of the symptomatology of his sleep apnea prior and after aggravation by his deviated nasal septum, as well as a request for outpatient treatment records from Brooke Army Medical Center dating back to 1984.

The Veteran died from non-Hodgkin's lymphoma, which was not service-connected. The Appellant did not provide evidence of herbicide exposure or any other basis for presumptive service connection.

The Board has determined that the reduction of the Veteran's disability rating for prostate cancer from 100% to 20%, effective November 1, 2011, was proper. The current residuals do not warrant a higher evaluation.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicides during his service in Thailand.

The Veteran's increased disability rating for DJD of the low back was granted, and a separate compensable disability rating for post operative residuals of hemorrhoidectomies with anal stricture was also granted. The Board found that referral for an extraschedular rating was not warranted.

The Board found that the Veteran's prostate cancer is not related to his service, including exposure to DDT. The preponderance of evidence does not support a finding that the Veteran's prostate cancer was incurred in or aggravated by service.